Mayne pharma launches generic version of Monodox in Australia
The drug is indicated for the treatment of a number of infections, including adjunctive therapy in severe acne
Australia's Mayne Pharma Group recently annou...
Insights into the latest developments in CDMO services and manufacturing.
Continue readingExpert perspectives on the evolving needs of injectable therapies and packaging.
Continue readingExploring the latest developments in inhalation technologies, respiratory delivery and sustainability
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement